Company Filing History:
Years Active: 2013
Title: Yuki Shiritani: Innovator in Peptide Technology
Introduction
Yuki Shiritani is a notable inventor based in Kyoto, Japan. She has made significant contributions to the field of peptide technology, particularly in the development of peptides with enhanced production efficiency. Her work has implications for various applications, including medical and biotechnological advancements.
Latest Patents
Yuki Shiritani holds a patent that focuses on a peptide containing a variable region, which is designed to improve production efficiency. The patent details the use of the peptide, methods for its production, and a solid support that has the peptide immobilized on it. This innovative peptide features an amino acid sequence that expresses a specific adsorption function, strategically located closer to the C-terminal than both the heavy-chain and light-chain variable regions.
Career Highlights
Throughout her career, Yuki has worked with reputable organizations, including Enplas Corporation and the Kyoto Institute of Technology. Her experience in these institutions has allowed her to refine her expertise in peptide research and development.
Collaborations
Yuki has collaborated with esteemed colleagues, including Yoichi Kumada and Michimasa Kishimoto. These partnerships have contributed to her innovative work and the advancement of peptide technology.
Conclusion
Yuki Shiritani's contributions to peptide technology exemplify her dedication to innovation and research. Her patent and collaborations highlight her role as a significant figure in the scientific community.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.